help(2), page-9

CCuyee1: No matter what TIS and or BIS had done, the result would have been the same

That's not true ccuyee1, BIS could have backed their original decision and TIS would have approval right now, they didn't, they backflipped on TIS and the rest is history. The design of the trials as agreed with the MHRA and BIS seemed to just fall by the side once BIS had to put their stamp on it.

Australian market is small, TIS should be attacking the US market as quickly as possible, otherwise holders won't see much value IMO.